comparing the icc and who classifications for secondary aml and their impact on clinical practice
Published 1 year ago • 358 plays • Length 3:20Download video MP4
Download video MP3
Similar videos
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
1:33
updates to the icc classification of aml
-
1:22
the importance of standardizing the classification of aml
-
4:39
aml & mds: mac or ric?
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:45
star vs. planet: what's the difference?
-
30:43
the art and science of choosing wisely
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
1:47
flow identification and monitoring of leukemia stem cells
-
1:21
intensive therapy of older aml
-
3:10
novel aml treament approaches
-
0:38
optimal time for allo-hsct in aml
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:45
gvhd & gvl in secondary aml
-
1:49
bringing precision medicine and mrd into clinical strategies
-
4:37
updates from uk ncri aml18
-
4:57
comparing icc and ihc results in determining breast cancer bio-markers
-
2:28
meet the leaders of the international chamber of commerce (icc)
-
2:18
molecular profiling and risk classification of patients with mpns and splanchnic vein thromboses
-
3:51
assessing high-risk aml
-
3:13
final results of bright aml 1003